SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-041632
Filing Date
2015-07-08
Accepted
2015-07-08 16:17:00
Documents
3
Period of Report
2015-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v415087_8k.htm 8-K 17325
2 LETTER TO STOCKHOLDERS v415087_ex99-1.htm EX-99.1 4804
4 GRAPHIC image_001.jpg GRAPHIC 11133
  Complete submission text file 0001144204-15-041632.txt   38948
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 15979294
SIC: 2835 In Vitro & In Vivo Diagnostic Substances